In this study, we demonstrated that the breast cancer stem-like cells, MCF-7/SC, possess prominent stem cell properties such as an enhanced CD44+/CD24− population, reduced ROS levels, and increased mammosphere formation ability compared with the parental MCF-7 cells (Figure 1a–e). This evidence concerns the gene CD44 and breast cancer.